Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - EPS
EPS AVTX - Avalo Therapeutics, Inc.
-114
LAST VALUE
77.92%
2 YEAR CAGR
49.08%
5 YEAR CAGR
0.00%
10 YEAR CAGR